Goldman Sachs analyst Georgina Fraser CFA maintained a Hold rating on Evonik (0QDS – Research Report) today and set a price target of €22.70. The company’s shares closed yesterday at €21.43.
In a report released today, Virginie Boucher-Ferte from Deutsche Bank maintained a Buy rating on Evonik (0QDS – Research Report), with a price target of €24.00. See what stocks are receiving ...